L, H. H. J., R, A., L, B. G., I, C. D. Z., P, L. C. S., L, N. B., . . . Papadopoulou, D. (2025). Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial. https://doi.org/10.1093/ndt/gfae132
Chicago Style (17th ed.) CitationL, Heerspink H. J., et al. Design and Baseline Characteristics of the Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) Randomized Trial. 2025. https://doi.org/10.1093/ndt/gfae132.
MLA (9th ed.) CitationL, Heerspink H. J., et al. Design and Baseline Characteristics of the Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) Randomized Trial. 2025. https://doi.org/10.1093/ndt/gfae132.